A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of CH505M5 N197D mRNA-gp160 Followed by CH505 TF mRNA-gp160 in Adults in Overall Good Health Without HIV.

Details

Language :

English

ISSN :

10742921

Database :

Supplemental Index

Journal :

Vaccine Weekly

Publication Type :

Periodical

Accession number :

179333119